Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Surg ; 248(6): 1060-6, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19092351

ABSTRACT

OBJECTIVE: To evaluate the effects of a single preoperative dose of steroid on thyroidectomy outcomes. BACKGROUND: Nausea, pain, and voice alteration frequently occur after thyroidectomy. Because steroids effectively reduce nausea and inflammation, a preoperative administration of steroids could improve these thyroidectomy outcomes. METHODS: Seventy-two patients (men = 20, women = 52) undergoing thyroidectomy for benign disease were included in this randomized, controlled, 2 armed (group D: 8 mg dexamethasone, n = 37; group C: 0.9% NaCl, n = 35), double-blinded study (clinical trial number NCT00619086). Anesthesia, surgical procedures, antiemetics, and analgesic treatments were standardized. Nausea (0-3), pain (visual analog scale), antiemetic and analgesic requirements, and digital voice recording were documented before and 4, 8, 16, 24, 36, and 48 hours after surgery. Patients were followed-up 30 days after hospital discharge. RESULTS: Baseline characteristics were similar among the 2 treatment groups. Nausea was pronounced in the first 16 hours postoperatively (scores were <0.3 and 0.8-1.0 for group D and C, respectively (P = 0.005)), and was significantly lower in group D compared with group C during the observation period (P = 0.001). Pain diminished within 48 hours after surgery (visual analog scale 20 and 35 in group D and C, respectively (P = 0.009)). Antiemetic and analgesic requirements were also significantly diminished. Changes in voice mean frequency were less prominent in the dexamethasone group compared with the placebo group (P = 0.015). No steroid-related complications occurred. CONCLUSION: A preoperative single dose of steroid significantly reduced nausea, vomiting, and pain, and improved postoperative voice function within the first 48 hours (most pronounced within 16 hours) after thyroid resection; this strategy should be routinely applied in thyroidectomies.


Subject(s)
Dexamethasone/administration & dosage , Glucocorticoids/administration & dosage , Pain, Postoperative/prevention & control , Postoperative Nausea and Vomiting/prevention & control , Preoperative Care , Thyroid Diseases/surgery , Voice , Adult , Aged , Aged, 80 and over , Double-Blind Method , Female , Hoarseness/epidemiology , Hoarseness/prevention & control , Humans , Male , Middle Aged , Severity of Illness Index , Thyroidectomy , Time Factors , Young Adult
2.
World J Surg ; 32(9): 1940-7, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18463918

ABSTRACT

BACKGROUND: Injuries of the recurrent laryngeal nerve with consecutive vocal cord paralysis is a typical complication in chest, esophageal, thyroideal, and neck surgery. Glottic insufficiency secondary to such a lesion can be treated by endolaryngeal vocal cord augmentation (injection laryngoplasty). Many different substances have been used, often showing complications or disadvantages. This study reports on the use of injectable polydimethylsiloxane (PDMS), with special regard to the long-term results. METHODS: In this prospective study, 21 patients with unilateral vocal cord paralysis underwent injection laryngoplasty using PDMS at a volume of 0.5-1.0 ml. Preoperatively, 6 weeks and 12 months after the injection the following parameters concerning patients' voice were evaluated: Glottic closure by videolaryngostroboscopy, maximum phonation time, voice range, voice dynamic, jitter, shimmer, noise-to-harmonic-ratio, and roughness, breathiness, and hoarseness (RBH). In addition, patients were asked to give their own evaluation of how satisfied they felt with their voice and of the handicaps it caused them. RESULTS: Postoperatively an improvement was evident in all the parameters that were investigated, and this significant improvement was still in evidence for most of the parameters more than one year after the injection. In our study no complications were observed more than one year after injection. CONCLUSION: PDMS is a safe substance for injection laryngoplasty in unilateral vocal cord paresis. Objective and subjective parameters confirm its effectiveness. It is suitable for obtaining satisfying results in the reestablishment of the patient's voice and communication ability.


Subject(s)
Dimethylpolysiloxanes/administration & dosage , Larynx/surgery , Recurrent Laryngeal Nerve/surgery , Vocal Cord Paralysis/surgery , Adult , Aged , Aged, 80 and over , Analysis of Variance , Female , Humans , Injections , Male , Middle Aged , Phonation , Recurrent Laryngeal Nerve Injuries , Treatment Outcome , Vocal Cord Paralysis/etiology
3.
Rhinology ; 43(3): 229-32, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16218519

ABSTRACT

Rosai-Dorfman disease is a rare, idiopathic, benign, histiocytic proliferation usually seen in younger patients. Most commonly neck lymph nodes are involved with a predominant infiltration of sinusoidal histiocytes. Nearly half of the patients have extranodal manifestation. Two cases of Rosai-Dorfman disease involving the nose and the paranasal sinuses are presented. The clinical presentation, radiographic findings, treatment and histological characteristics of the disease are discussed.


Subject(s)
Histiocytosis, Sinus/diagnostic imaging , Histiocytosis, Sinus/pathology , Nasal Cavity/diagnostic imaging , Nasal Cavity/pathology , Paranasal Sinuses/diagnostic imaging , Paranasal Sinuses/pathology , Adult , Histiocytosis, Sinus/therapy , Humans , Male , Middle Aged , Radiography
SELECTION OF CITATIONS
SEARCH DETAIL
...